Invention Grant
- Patent Title: Compositions of 1,3-butanediol and beta-hydroxybutyric acid to provide optimal therapeutic ketosis
-
Application No.: US17822727Application Date: 2022-08-26
-
Publication No.: US12059398B2Publication Date: 2024-08-13
- Inventor: Geoffrey Hubert Woo , Christine Ensley , Latt Shahril Mansor
- Applicant: Health Via Modern Nutrition Inc.
- Applicant Address: US CA San Francisco
- Assignee: Health Via Modern Nutrition Inc.
- Current Assignee: Health Via Modern Nutrition Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Kirton McConkie
- Agent David R. Conklin
- Main IPC: A61K31/19
- IPC: A61K31/19 ; A23G1/42 ; A23L2/02 ; A23L2/52 ; A23L33/10 ; A61K9/00 ; A61K31/047

Abstract:
Nutritional compositions contain a mixture of ketogenic ingredients including from 80 to 99% weight % 1,3-butanediol (BDO), preferably R-1,3-butanediol, and from 1 to 20 weight % beta-hydroxybutyric acid (BHB), preferably D-beta-hydroxybutyric acid, or an equivalent molar amount of its conjugate base beta-hydroxybutyrate, salts, monoesters, polyesters, or mixtures thereof. In some embodiments, the nutritional compositions for providing ketosis are prepared for oral administration in a solid form, such as bars, bites, tablets, pills or capsules, in a liquid form, such as smoothies, goos, water, carbonated beverages, soft drinks, fermented beverage suspensions, solutions and emulsions, or in a powder form that can be used to prepare drink mixes or can be added as a supplement to other food or drink products. Methods of providing ketosis in a subject include delivering optimal therapeutic ketosis, with rapidity into and extended duration of blood concentrations of D-BHB of between 1 mM and 2.5 mM.
Public/Granted literature
- US20240065991A1 COMPOSITIONS OF 1,3-BUTANEDIOL AND BETA-HYDROXYBUTYRIC ACID TO PROVIDE OPTIMAL THERAPEUTIC KETOSIS Public/Granted day:2024-02-29
Information query